CoChat
Sign Up
Cited by 161Attention Deficit Hyperactivity DisorderPharmaceutical studies and practicesCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Cardiovascular Monitoring and Stimulant Drugs for Attention-Deficit/Hyperactivity Disorder

Perrin, James M., Friedman, Richard A., Knilans, Timothy K., the Black Box Working Group, the Section on Cardiology and Cardiac Surgery·2008·Pediatrics
DOI 10.1542/peds.2008-1573
Open this paper in CoChat — free account

Abstract

A recent American Heart Association (AHA) statement1 recommended electrocardiograms (ECGs) routinely for children before they start medications to treat attention-deficit/hyperactivity disorder (ADHD). The AHA statement reflected the thoughtful work of a group committed to improving the health of children with heart disease. However, the recommendation to obtain an ECG before starting medications for treating ADHD contradicts the carefully considered and evidence-based recommendations of the American Academy of Child and Adolescent Psychiatry2 and the American Academy of Pediatrics (AAP).3,4 These organizations have concluded that sudden cardiac death (SCD) in persons taking medications for ADHD is a very rare event, occurring at rates no higher than those in the general population of children and adolescents. Both of these groups also noted the lack of any evidence that the routine use of ECG screening before beginning medication for ADHD treatment would prevent sudden death. The AHA statement pointed out the importance of detecting silent but clinically important cardiac conditions in children and adolescents, which is a goal that the AAP shares. The primary purpose of the AHA statement is to prevent cases of SCD that may be related to stimulant medications. The recommendations of the AAP and the rationale for these recommendations are the subject of this statement. This statement has been endorsed by the American Academy of Child and Adolescent Psychiatry, the Society for…

Overview

Integrity signals

Registry

Crossref · 10.1542/peds.2008-1573

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 16 references

Research works printed but not linked: 2

  1. American Heart Association. American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medication for ADHD [press release]. Available at: http://americanheart.mediaroom.com/index.php?s=43&item=422. Accessed May 28, 2008
  2. American Heart Association. Correction: cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs—a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing. Available at: http://circ.ahajournals.org/cgi/data/CIRCULATIONAHA.107.189473/DC1/1. Accessed May 28, 2008

Cited by

Sorted by citations

See all 161

Related

Metadata

Authors
Perrin, J. M., Friedman, R. A., Knilans, T. K., the Black Box Working Group, & Surgery, T. S. O. C. A. C.
ORCID
Venue
Pediatrics
Publisher
American Academy of Pediatrics (AAP)
Published
2008-08-01
Volume
122
Issue
2
Pages
451-453
ISSN
  • 0031-4005 (ISSN-L)
  • 1098-4275
DOI
10.1542/peds.2008-1573
OpenAlex
W2122369545
Cited by
161
References
16
Citations by year
2026: 2 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 3 · 2019: 2 · 2018: 6 · 2017: 4 · 2016: 11 · 2015: 9 · 2014: 10 · 2013: 7 · 2012: 25
FWCI
15.82
Type
journal article
Language
en
Open access
closed
Locations
  • PEDIATRICS (publishedVersion)
  • PubMed (publishedVersion)
Funders
American Heart Association
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
attention deficit hyperactivity disorder, stimulant medication, sudden cardiac death, electrocardiogram screening, cardiovascular monitoring, American Heart Association guidelines, American Academy of Child and Adolescent Psychiatry, children and adolescents
MeSH terms
Adolescent, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Cardiovascular Diseases, Child, Child, Preschool, Electrocardiography, Female, Follow-Up Studies, Humans, Male, Monitoring, Physiologic, Policy Making, Societies, Medical, Death, Sudden, Cardiac, Practice Guidelines as Topic, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review